The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 8-14 August 2021, and includes updates on COVID-19, West Nile virus disease, Vibrio growth in the Baltic Sea, Marburg virus disease, and the Olympic Games in Tokyo.
These report presents the results of the EQA on antimicrobial susceptibility testing (AST) for national public health laboratories for Campylobacter within the Food‐ and Waterborne Diseases and Zoonoses Network (FWD-Net).
A sizeable proportion of Salmonella and Campylobacter bacteria is still resistant to antibiotics commonly used in humans and animals, as in previous years, says a report released today by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
In 2018–2019, data on antimicrobial resistance in zoonotic and indicator bacteria, submitted by 28 EU Member States (MSs), were jointly analysed by the EFSA and the ECDC.
The number of reported human cases of illness caused by Campylobacter and Salmonella bacteria across Europe appears to have stabilised over the past five years, according to the latest report on zoonotic diseases by EFSA and ECDC.
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2019 in 36 European countries (28 Member States (MS) and eight non-MS).
For 2018, 63 cases of diphtheria were reported to ECDC; 62 due to toxigenic Corynebacterium diphtheriae or C. ulcerans and one case with an unknown pathogen. The highest proportion of C. ulcerans cases was among adults 65 years and over, whereas C. diphtheriae cases were more common in younger age groups. Among the C. diphtheriae cases, 60% were reported as imported. High vaccination coverage is crucial to prevent diphtheria.